Category:
Changes in inflammatory bowel disease patients’ perspectives on biosimilars: A follow-up survey
October, 2019
The aim of this survey was to find out whether the perspectives of patients with inflammatory bowel disease concerning biosimilars have changed since the publication of our last survey carried out in 2014–2015.